Mar 13, 2025 08:34AM
Mar 13, 2025 08:34AM
Mar 11, 2025 04:04PM
Mar 4, 2025 04:02PM
Feb 25, 2025 04:07PM
Jan 6, 2025 08:32AM
Dec 3, 2024 08:34AM ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category
Nov 14, 2024 08:32AM
Nov 7, 2024 08:34AM
Nov 7, 2024 08:32AM
Oct 31, 2024 04:04PM
Oct 28, 2024 08:32AM
Oct 24, 2024 08:32AM
Oct 23, 2024 08:34AM ChromaDex to Participate in the 17th Annual LD Micro Main Event
Oct 15, 2024 08:32AM
Sep 20, 2024 08:32AM
Sep 20, 2024 08:32AM
Sep 10, 2024 08:33AM
Sep 10, 2024 08:32AM
Aug 19, 2024 08:32AM
Aug 7, 2024 04:04PM ChromaDex Corporation Reports Second Quarter 2024 Financial Results
Jul 23, 2024 08:32AM
Jul 23, 2024 08:32AM
Jul 16, 2024 08:34AM
Jul 15, 2024 08:29AM
Jul 1, 2024 08:32AM
Jun 13, 2024 08:32AM
Jun 7, 2024 08:35AM ChromaDex (CDXC) Receives Exclusive U.S. FDA Orphan Drug Designation and Rare Pediatric Disease Designation for Nicotinamide Riboside Chloride (NRC) for the Treatment of Ataxia Telangiectasia
Jun 7, 2024 08:34AM
Apr 30, 2024 08:32AM
Dec 12, 2023 10:30AM
Nov 11, 2022 08:13AM
Nov 11, 2022 08:12AM
Oct 24, 2022 08:32AM
Oct 11, 2022 07:34AM ChromaDex (CDXC) Sells 3.8M Shares to Nestle at $1.31/sh, Enter Commercial Supply Agreement for Niagen
Oct 11, 2022 07:32AM
Oct 3, 2022 07:30AM
Sep 20, 2022 05:52AM
Sep 19, 2022 06:05PM
Sep 1, 2022 06:35AM
Sep 1, 2022 06:32AM
Aug 15, 2022 06:35AM ChromaDex (CDXC) Announces Thorne Research Loses Patent Litigation
Aug 15, 2022 06:34AM
Jun 10, 2022 06:33AM
Jun 10, 2022 06:32AM
Jun 2, 2022 06:35AM
Jun 2, 2022 06:34AM
Jan 20, 2022 06:34AM
Jan 20, 2022 06:33AM ChromaDex and Designs for Health Partner for New Product Development on Niagen®
Sep 29, 2021 06:37AM

322,951 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All